Zai Lab Announces Proposed Public Offering of American Depositary Shares

NEXT STORY
Corvus Pharmaceuticals to Provide Business Update and Report First Quarter 2019 Financial Results on May 9, 2019
PREV STORY
MacroGenics Provides Update on Corporate Progress and First Quarter 2019 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immune Design to Present at Upcoming Investor Conferences in September

SEATTLE and SOUTH SAN FRANCISCO, Calif., Sept. 01, 2017 (GLOBE NEWSWIRE) -- Immune Design ...

author_avatar
NASDAQ Market News

Myriad RBM DiscoveryMAP(R) Technology Identifies Novel Biomarkers That May Predict Increased Risk of Cardiovascular Events in Patients With Diabetes

SALT LAKE CITY, Nov. 16, 2015 (GLOBE NEWSWIRE) -- Myriad RBM, a wholly-owned subsidiary ...

author_avatar
NASDAQ Market News

ContraFect to Participate in World Antimicrobial Resistance Congress 2018

YONKERS, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology ...

author_avatar
NASDAQ Market News